Inaba T, Ishizuka K, Yuasa S, Mishima N, Ogura K, Saito K, Kohno T, Fujitomo Y, Nakanishi M, Fujita N
Department of Infection Control and Laboratory Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Department of Medical Instrumental Research and Technology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Int J Lab Hematol. 2016 Feb;38(1):27-33. doi: 10.1111/ijlh.12423. Epub 2015 Sep 3.
Pentra MS CRP is an automated hematology analyzer capable of cytochemistry using Chlorazol black E, a lipid-staining agent, for white blood cell (WBC) differentials. Pentra MS CRP displays a WBC scattergram according to the cell volume obtained using flow impedance and light absorbance reflecting the Chlorazol black E (CBE)-positive lipid content.
Neutrophil scattergrams obtained using Pentra MS CRP were compared between 5 patients with myelodysplastic syndrome (MDS) and normal controls. Sudan black B (SBB)-staining patterns of peripheral blood neutrophils were subdivided into four types (types I, II, III, and VI) based on their staining intensity and scored by counting 200 cells. Such SBB scores were also compared between the two groups.
Neutrophil scattergrams deviated downward in the MDS group, suggesting the decreased CBE positivity that seemed reflect the reduction of the lipid content in dysplastic neutrophils. SBB scores determined in this study were also decreased in the MDS group when compared with those in normal controls.
Pentra MS CRP might rapidly generate useful information on dysplastic neutrophils in patients with MDS based on its cytochemistry for WBC differentials during routine laboratory hematology.
Pentra MS CRP是一种自动化血液分析仪,能够使用氯唑黑E(一种脂质染色剂)进行细胞化学分析,用于白细胞(WBC)分类。Pentra MS CRP根据使用流动阻抗和吸光度获得的细胞体积显示白细胞散点图,该吸光度反映了氯唑黑E(CBE)阳性脂质含量。
比较了5例骨髓增生异常综合征(MDS)患者和正常对照使用Pentra MS CRP获得的中性粒细胞散点图。外周血中性粒细胞的苏丹黑B(SBB)染色模式根据染色强度分为四种类型(I、II、III和VI型),并通过计数200个细胞进行评分。两组之间也比较了这种SBB评分。
MDS组中性粒细胞散点图向下偏移,提示CBE阳性率降低,这似乎反映了发育异常中性粒细胞中脂质含量的减少。与正常对照组相比,本研究中测定的MDS组SBB评分也降低。
Pentra MS CRP在常规实验室血液学检查中,基于其白细胞分类的细胞化学分析,可能会快速生成有关MDS患者发育异常中性粒细胞的有用信息。